Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at Oppenheimer Healthcare Conference Transcript

Mar 19, 2019 / 06:10PM GMT
Release Date Price: €110.34 (+2.40%)
Mike Wiederhorn
Oppenheimer & Co. - Analyst

Good afternoon. I am Mike Wiederhorn. Welcome to Oppenheimer's 29th annual healthcare conference. It is my pleasure to introduce Amedisys, President and CEO Paul Kusserow and Chief Financial Officer Scott Ginn.

Welcome.

Paul Kusserow
Amedisys, Inc. - President and CEO

Thank you. Thank you, Mike.

Mike Wiederhorn
Oppenheimer & Co. - Analyst

So what we are going to do is fireside. So we will start, just go right into it, start with the number one question I'm sure you have heard today. Can you update us on the progress in Washington around PDGM and the behavioral adjustment? Kind of where that's at, where you think that is going.

And then a second part: is there any chance legislatively, the stuff that was introduced, has any chance of going through? And it could be attached on any potential legislation in the future?

Paul Kusserow
Amedisys, Inc. - President and CEO

Sure. So first of all, excuse my

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot